NCT00441909View on ClinicalTrials.gov

Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
HIV Infections
Interventions
DRUG

UC-781

0.1% UC-781 Vaginal Gel

DRUG

UC-781 placebo

Vaginal Gel Placebo

Trial Locations (1)

Unknown

Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

CONRAD

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00441909 - Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide | Biotech Hunter | Biotech Hunter